Tag: drug safety
Ivermectin and cancer: why social media outpaces scientific evidence
Ivermectin shows activity against some cancer cell lines in laboratory settings, but lacks clinical trial evidence in humans. The gap…
Hormonal Contraceptives With Progestogen Linked to Slightly Elevated Meningioma Risk
A 25-year Danish register study linked progestogen-containing oral contraceptives to a modestly elevated meningioma risk. The Danish Medicines Agency has…
MHRA Safety Roundup: June 2026 — Key Drug and Device Alerts for Clinicians
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published its June 2026 safety roundup, consolidating critical alerts for…
Taiwan develops algorithm to identify pregnancies and estimate gestational age from health records
Researchers in Taiwan developed a hierarchical algorithm to identify pregnancies and estimate gestational age from nationwide health insurance data, enabling…
AI Model Detects Adverse Drug Events in Electronic Health Records with High Accuracy
A large language model successfully identifies adverse drug events from clinical notes, automating post-marketing drug safety surveillance and potentially enabling…
How statistical paradoxes mislead drug safety decisions—and why AI may help
Statistical reasoning errors in drug safety evaluation—including the prosecutor's fallacy and Simpson's paradox—systematically distort causality judgments and remain inadequately audited…
ACE Inhibitors and Angioedema: Why Distinguishing Drug Types Matters for Treatment
ACE inhibitors can cause two distinct forms of angioedema with different treatment requirements. Bradykinin-mediated cases do not respond to standard…
UK Health Regulator Issues Class 4 Alert for Denosumab Injection Labelling Error
MHRA issues Class 4 alert for Ponlimsi denosumab after Teva UK reports carton labelling error stating "For application to the…